AstraZeneca plc vs Global X Copper Miners ETF — how do they compare? AstraZeneca plc trades at $157.96 (market cap $248.14B), while Global X Copper Miners ETF trades at $89.4. The key difference: AstraZeneca plc pays a 2.01% dividend while Global X Copper Miners ETF pays none, and Global X Copper Miners ETF is trading nearer its 52-week high, AstraZeneca plc nearer its low. Which is the better fit depends on your goals.
| AZN | COPX | |
|---|---|---|
Market Cap | $248.14B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $209.48 | $95.70 |
52-Week Low | $147.06 | $46.08 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | — |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →COPX tracks the Solactive Global Copper Miners Total Return Index, providing broad exposure to companies worldwide involved in copper mining, refining, and exploration. It serves as an equity-based alternative to copper futures, offering a leveraged play on copper demand driven by global infrastructure and the clean energy transition.
Read more on COPX →